Incorporation, release, and effectiveness of dexamethasone in poly (lactic-co-glycolic acid) nanoparticles for inner ear drug delivery

Journal of Nanotechnology in Engineering and Medicine

Volumn 2, Issue 1, 2011, Pages

  Wang, Youdan ^a   Gao, Xinsheng ^a   Kuriyavar, Satish ^a   Bourne, David ^b   Grady, Brian ^c   Chen, Kejian ^a   Dormer, Kenneth ^d   Kopke, Richard D ^a  

^a Hough Ear Institute   (Japan)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c University of Oklahoma   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Dexamethasone; Drug loading; Nanoparticles; Superparamagnetic iron oxide; Sustained release

Indexed keywords

DRUG PRODUCTS; EFFICIENCY; IRON OXIDES; NANOPARTICLES; ORGANIC POLYMERS; SUPERPARAMAGNETISM; TARGETED DRUG DELIVERY;

DEXAMETHASONES; DRUG LOADING; DRUG-LOADING EFFICIENCY; POLY LACTIC-CO-GLYCOLIC ACID; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDES; SUSTAINED RELEASE;

CONTROLLED DRUG DELIVERY;

EID: 79951573148     PISSN: 19492944     EISSN: 19492952     Source Type: Journal    
DOI: 10.1115/1.4002928     Document Type: Article

References (34)

1. Hiraumi, H., Nakagawa, T., and Ito, J., 2009, "Efficiency of a Transtympanic Approach to the Round Window Membrane Using a Microendoscope," Eur. Arch. Otorhinolaryngol., 266(3), pp. 367-371.
2. Witte, M. C., and Kasperbauer, J. L., 2000, "Round Window Membrane Permeability to Transforming Growth Factor-Alpha: An In Vitro Study," Otolaryngol.-Head Neck Surg., 123(1), pp. 91-96.
3. Sun, J. J., Liu, Y., Kong, W. J., Jiang, P., and Jiang, W., 2007, "In Vitro Permeability of Round Window Membrane to Transforming Dexamethasone With Delivery Vehicles-A Dosage Estimation," Chin. Med. J. (Engl), 120(24), pp. 2284-2289.
4. Li, G. M., Frenz, D. A., Brahmblatt, S., Feghali, J. G., Ruben, R. J., Berggren, D., Arezzo, J., and Van De Water, T. R., 2001, "Round Window Membrane Delivery of L-Methionine Provides Protection From Cisplatin Ototoxicity Without Compromising Chemotherapeutic Efficacy," Neurotoxicology, 22(2), pp. 163-176.
5. Plontke, S. K., Zimmermann, R., Zenner, H. P., and Lowenheim, H., 2006, "Technical Note on Microcatheter Implantation for Local Inner Ear Drug Delivery: Surgical Technique and Safety Aspects," Otol. Neurotol., 27(7), pp. 912-917.
6. Kopke, R. D., Wassel, R. A., Mondalek, F., Grady, B., Chen, K. J., Liu, J. Z., Gibson, D., and Dormer, K. J., 2006, "Magnetic Nanoparticles: Inner Ear Targeted Molecule Delivery and Middle Ear Implant," Audiol. Neuro-Otol., 11(2), pp. 123-133.
7. Paulson, D. P., Abuzeid, W., Jiang, H., Oe, T., O'Malley, B. W., and Li, D. Q., 2008, "A Novel Controlled Local Drug Delivery System for Inner Ear Disease," Laryngoscope, 118(4), pp. 706-711.
8. Blum, J. S., and Saltzman, W. M., 2008, "High Loading Efficiency and Tunable Release of Plasmid DNA Encapsulated in Submicron Particles Fabricated From PLGA Conjugated With Poly-L-Lysine," J. Controlled Release, 129(1), pp. 66-72.
9. de la Fuente, M., Csaba, N., Garcia-Fuentes, M., and Alonso, M. J., 2008, "Nanoparticles as Protein and Gene Carriers to Mucosal Surfaces," Nanomedicine, 3(6), pp. 845-857.
10. Kafka, E. L., Braden, A., and Vishwanatha, J. K., 2008, "Characterization of Nanoparticle-Mediated Drug Delivery to NB4: Feasibility of Nanoparticle Use for Cells in Suspension and Blood Diseases," Journal of Biomedical Nanotechnology, 4(2), pp. 196-202.
11. Khang, G., Rhee, J. M., Jeong, J. K., Lee, J. S., Kim, M. S., Cho, S. H., and Lee, H. B., 2003, "Local Drug Delivery System Using Biodegradable Polymers," Macromolecular Research, 11(4), pp. 207-223.
12. Dormer, K. J., Wassel, R., Kopke, R., Chen, K., Grady, B., and Vasquez, A., 2007, "Superparamagnetic-PLGA Non-Viral Vectors for Inner Ear Therapy," FASEB J., 21(6), p. A825.
13. Dormer, K. J., Awasthi, V., Galbraith, W., Kopke, R. D., Chen, K., and Wassel, R., 2008, "Magnetically-Targeted, Technetium 99m-Labeled Nanoparticles to the Inner Ear," Journal of Biomedical Nanotechnology, 4(2), pp. 174-184.
14. Kopke, R. D., Hoffer, M. E., Wester, D., O'Leary, M. J., and Jackson, R. L., 2001, "Targeted Topical Steroid Therapy in Sudden Sensorineural Hearing Loss," Otol. Neurotol., 22(4), pp. 475-479.
15. Vivero, R. J., Joseph, D. E., Angeli, S., He, J., Chen, S. B., Eshraghi, A. A., Balkany, T. J., and Van De Water, T. R., 2008, "Dexamethasone Base Conserves Hearing From Electrode Trauma-Induced Hearing Loss," Laryngoscope, 118(11), pp. 2028-2035.
16. Dinh, C., Hoang, K., Haake, S., Chen, S. B., Angeli, S., Nong, E., Eshraghi, A. A., Balkany, T. J., and Van De Water, T. R., 2008, "Biopolymer-Released Dexamethasone Prevents Tumor Necrosis Factor Alpha-Induced Loss of Auditory Hair Cells In Vitro: Implications Toward the Development of a Drug- Eluting Cochlear Implant Electrode Array," Otol. Neurotol., 29(7), pp. 1012-1019.
17. Dinh, C. T., Haake, S., Chen, S., Hoang, K., Nong, E., Eshraghi, A. A., Balkany, T. J., and De Water, T. R. V., 2008, "Dexamethasone Protects Organ of Corti Explants Against Tumor Necrosis Factor-Alpha-Induced Loss of Auditory Hair Cells and Alters the Expression Levels of Apoptosis-Related Genes," Neuroscience, 157(2), pp. 405-413.
18. Borkholder, D. A., 2008, "State-of-the-Art Mechanisms of Intracochlear Drug Delivery," Curr. Opin. Otolaryngol. Head Neck Surg., 16(5), pp. 472-477.
19. Gao, X., Chen, K., and Kopke, R., 2008, "Protective Effects of GSHe on Cochlear Hair Cells From 4-HNE and Neomycin Ototoxicity," Baltimore, MD.
20. Bilati, U., Allemann, E., and Doelker, E., 2003, "Sonication Parameters for the Preparation of Biodegradable Nanocapsules of Controlled Size by the Double Emulsion Method," Pharm. Dev. Technol., 8(1), pp. 1-9.
21. Wassel, R. A., Grady, B., Kopke, R. D., and Dormer, K. J., 2007, "Dispersion of Super Paramagnetic Iron Oxide Nanoparticles in Poly(D,L-Lactide-Co- Glycolide) Microparticles," Colloids Surf., A, 292(2-3), pp. 125-130.
22. Song, X. R., Zhao, Y., Wu, W. B., Bi, Y. Q., Cai, Z., Chen, Q. H., Li, Y. B., and Hou, S. X., 2008, "PLGA Nanoparticles Simultaneously Loaded With Vincristine Sulfate and Verapamil Hydrochloride: Systematic Study of Particle Size and Drug Entrapment Efficiency," Int. J. Pharm., 350(1-2), pp. 320-329.
23. Tewes, F., Munnier, E., Antoon, B., Okassa, L. N., Cohen-Jonathan, S., Marchais, H., Douziech-Eyrolles, L., Souce, M., Dubois, P., and Chourpa, I., 2007, "Comparative Study of Doxorubicin-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Prepared by Single and Double Emulsion Methods," Eur. J. Pharm. Biopharm., 66(3), pp. 488-492.
24. Zigoneanu, I. G., Astete, C. E., and Sabliov, C. M., 2008, "Nanoparticles With Entrapped Alpha-Tocopherol: Synthesis, Characterization, and Controlled Release," Nanotechnology, 19(10), p. 105606.
25. Gomez-Gaete, C., Fattal, E., Silva, L., Besnard, M., and Tsapis, N., 2008, "Dexamethasone Acetate Encapsulation Into Trojan Particles," J. Controlled Release, 128(1), pp. 41-49.
26. Niwa, T., Takeuchi, H., Hino, T., Kunou, N., and Kawashima, Y., 1993, "Preparations of Biodegradable Nanospheres of Water-Soluble and Insoluble Drugs With D,L-Lactide Glycolide Copolymer by a Novel Spontaneous Emulsification Solvent Diffusion Method, and the Drug Release Behavior," J. Controlled Release, 25(1-2), pp. 89-98.
27. Thote, A. J., Chappell, J. T., Gupta, R. B., and Kumar, R., 2005, "Reduction in the Initial-Burst Release by Surface Crosslinking of PLGA Microparticles Containing Hydrophilic or Hydrophobic Drugs," Drug Dev. Ind. Pharm., 31(1), pp. 43-57.
28. Jaraswekin, S., Prakongpan, S., and Bodmeier, R., 2007, "Effect of Poly(Lactide-Co-Glycolide) Molecular Weight on the Release of Dexamethasone Sodium Phosphate From Microparticles," J. Microencapsul., 24(2), pp. 117-128.
29. Eroglu, H., Kas, H. S., Oner, L., Turkoglu, O. F., Akalan, N., Sargon, M. F., and Ozer, N., 2001, "The In-Vitro and In-Vivo Characterization of PLGA: L-PLA Microspheres Containing Dexamethasone Sodium Phosphate," J. Microencapsul., 18(5), pp. 603-612.
30. Langer, R., 1990, "New Methods of Drug Delivery," Science, 249(4976), pp. 1527-1533.
31. Einmahl, S., Zignani, M., Varesio, E., Heller, J., Veuthey, J. L., Tabatabay, C., and Gurny, R., 1999, "Concomitant and Controlled Release of Dexamethasone and 5-Fluorouracil From Poly(Ortho Ester)," Int. J. Pharm., 185(2), pp. 189-198.
32. Gomez-Graete, C., Tsapis, N., Besnard, M., Bochot, A., and Fattal, E., 2007, "Encapsulation of Dexamethasone Into Biodegradable Polymeric Nanoparticles," Int. J. Pharm., 331(2), pp. 153-159.
33. Xu, J. F., Wang, Y. S., Li, Y., Yang, X. M., Zhang, P., Hou, H. Y., Shi, Y. Y., and Song, C. X., 2007, "Inhibitory Efficacy of Intravitreal Dexamethasone Acetate-Loaded PLGA Nanoparticles on Choroidal Neovascularization in a Laser-Induced Rat Model," J. Ocul. Pharmacol. Ther., 23(6), pp. 527-540.
34. Sha, S.-H., Taylor, R., Forge, A., and Schacht, J., 2001, "Differential Vulnerability of Basal and Apical Hair Cells Is Based on Intrinsic Susceptibility to Free Radicals," Hear. Res., 155(1-2), pp. 1-8.